Union Therapeutics
PrivateLast Round
Convertible Debt
May 1, 2024
Total Funding Raised
$59.17M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Union Therapeutics is a clinical-stage pharmaceutical company that identifies, develops, and commercializes treatments for immunology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Union Therapeutics Comparables
Compare Union Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Newsoara Biopharma Co., Ltd. | 79% | |
| Can Fite Biopharma Ltd ADR | 78% | |
| Aclaris Therapeutics | 77% |
Union Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | May 1, 2024 | ||||
| Growth Equity | Jul 14, 2023 | ||||
| Private Placement | Dec 1, 2022 | ||||
| Series B | Feb 9, 2021 | ||||
| Debt | Dec 1, 2019 | ||||
Debt | Jan 1, 2018 |
Union Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Board of Directors | Convertible Debt |
| European Investment Bank Group | Debt |
| T&W Medical | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 112% MoM, reaching 1.8K.
Union Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access